PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NWG vs. GSK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NWG and GSK is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.3

Performance

NWG vs. GSK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NatWest Group plc (NWG) and GlaxoSmithKline plc (GSK). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%100.00%NovemberDecember2025FebruaryMarchApril
-89.31%
79.44%
NWG
GSK

Key characteristics

Sharpe Ratio

NWG:

2.70

GSK:

-0.11

Sortino Ratio

NWG:

3.22

GSK:

0.01

Omega Ratio

NWG:

1.43

GSK:

1.00

Calmar Ratio

NWG:

0.88

GSK:

-0.10

Martin Ratio

NWG:

21.25

GSK:

-0.19

Ulcer Index

NWG:

3.91%

GSK:

15.39%

Daily Std Dev

NWG:

30.72%

GSK:

24.92%

Max Drawdown

NWG:

-98.38%

GSK:

-55.21%

Current Drawdown

NWG:

-89.45%

GSK:

-12.05%

Fundamentals

Market Cap

NWG:

$48.32B

GSK:

$79.23B

EPS

NWG:

$1.35

GSK:

$1.61

PE Ratio

NWG:

8.78

GSK:

24.23

PEG Ratio

NWG:

0.55

GSK:

0.39

Total Revenue (TTM)

NWG:

$14.99B

GSK:

$24.01B

Gross Profit (TTM)

NWG:

$18.60B

GSK:

$16.98B

EBITDA (TTM)

NWG:

$1.77B

GSK:

$5.14B

Returns By Period

In the year-to-date period, NWG achieves a 20.54% return, which is significantly higher than GSK's 16.61% return. Over the past 10 years, NWG has outperformed GSK with an annualized return of 5.81%, while GSK has yielded a comparatively lower 2.96% annualized return.


NWG

YTD

20.54%

1M

1.40%

6M

39.79%

1Y

79.07%

5Y*

44.22%

10Y*

5.81%

GSK

YTD

16.61%

1M

1.51%

6M

3.96%

1Y

-2.27%

5Y*

5.22%

10Y*

2.96%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NWG vs. GSK — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NWG
The Risk-Adjusted Performance Rank of NWG is 9494
Overall Rank
The Sharpe Ratio Rank of NWG is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of NWG is 9595
Sortino Ratio Rank
The Omega Ratio Rank of NWG is 9595
Omega Ratio Rank
The Calmar Ratio Rank of NWG is 8383
Calmar Ratio Rank
The Martin Ratio Rank of NWG is 9999
Martin Ratio Rank

GSK
The Risk-Adjusted Performance Rank of GSK is 4646
Overall Rank
The Sharpe Ratio Rank of GSK is 4848
Sharpe Ratio Rank
The Sortino Ratio Rank of GSK is 4141
Sortino Ratio Rank
The Omega Ratio Rank of GSK is 4141
Omega Ratio Rank
The Calmar Ratio Rank of GSK is 4848
Calmar Ratio Rank
The Martin Ratio Rank of GSK is 5050
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NWG vs. GSK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for NatWest Group plc (NWG) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for NWG, currently valued at 2.70, compared to the broader market-2.00-1.000.001.002.003.00
NWG: 2.70
GSK: -0.11
The chart of Sortino ratio for NWG, currently valued at 3.22, compared to the broader market-6.00-4.00-2.000.002.004.00
NWG: 3.22
GSK: 0.01
The chart of Omega ratio for NWG, currently valued at 1.43, compared to the broader market0.501.001.502.00
NWG: 1.43
GSK: 1.00
The chart of Calmar ratio for NWG, currently valued at 0.88, compared to the broader market0.001.002.003.004.005.00
NWG: 0.88
GSK: -0.10
The chart of Martin ratio for NWG, currently valued at 21.25, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
NWG: 21.25
GSK: -0.19

The current NWG Sharpe Ratio is 2.70, which is higher than the GSK Sharpe Ratio of -0.11. The chart below compares the historical Sharpe Ratios of NWG and GSK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00NovemberDecember2025FebruaryMarchApril
2.70
-0.11
NWG
GSK

Dividends

NWG vs. GSK - Dividend Comparison

NWG's dividend yield for the trailing twelve months is around 4.59%, more than GSK's 3.98% yield.


TTM20242023202220212020201920182017201620152014
NWG
NatWest Group plc
4.59%4.37%9.24%11.32%2.73%4.58%9.76%0.91%0.00%0.00%0.00%0.00%
GSK
GlaxoSmithKline plc
3.98%4.60%3.75%4.78%4.92%5.49%4.28%5.55%5.72%7.06%5.96%6.09%

Drawdowns

NWG vs. GSK - Drawdown Comparison

The maximum NWG drawdown since its inception was -98.38%, which is greater than GSK's maximum drawdown of -55.21%. Use the drawdown chart below to compare losses from any high point for NWG and GSK. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-89.45%
-12.05%
NWG
GSK

Volatility

NWG vs. GSK - Volatility Comparison

NatWest Group plc (NWG) has a higher volatility of 10.42% compared to GlaxoSmithKline plc (GSK) at 6.83%. This indicates that NWG's price experiences larger fluctuations and is considered to be riskier than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%NovemberDecember2025FebruaryMarchApril
10.42%
6.83%
NWG
GSK

Financials

NWG vs. GSK - Financials Comparison

This section allows you to compare key financial metrics between NatWest Group plc and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab